Cassava sciences responds to allegations

Austin, texas, aug. 25, 2021 (globe newswire) -- cassava sciences, inc. (nasdaq: sava), a biotechnology company focused on alzheimer's disease, today issued a response to claims that were posted on-line yesterday after market hours. cassava sciences believes the claims made in this post regarding scientific integrity are false and misleading. the company stands behind its science, its scientists and its scientific collaborators, and is responding to ensure the facts are known and respected.
SAVA Ratings Summary
SAVA Quant Ranking